Neuromodulation Devices Consumables and Associated Products 2023

A Contract Award Notice
by NHS SUPPLY CHAIN

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£90M-£156M
Sector
HEALTH
Published
24 Nov 2023
Delivery
not specified
Deadline
n/a

Concepts

Location

United Kingdom: Various Locations in the UK

Geochart for 1 buyers and 29 suppliers

1 buyer

24 suppliers

Description

"Non-exclusive Framework Agreement (FAG) for the supply to the NHS Supply Chain customer base via the E-Direct Route. Product range to include, but not limited to stimulation of; Deep Brain, Spinal Cord, Sacral Nerve, Vagal Nerve, Dorsal Route Ganglion, Peripheral Nerve, Radio Frequency Pain Management, Intrathecal Brug Delivery Pumps, Dorsal Ramus Medial Branch nerve and other devices that provide nerve stimulation or pain management that meet the requirements of users and patients. The FAG will provide access to Neuromodulation Devices/Consumables that are associated with Neuromodulation procedures. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £92,000,000.00 the term of FAG, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the FAG. The estimated value over the total FAG term (including any extension options) is £392,000,000.00"

Lot Division

1 Deep Brain Stimulation

"Neuromodulation Product range to include, but not limited to the supply of; Deep Brain Stimulation. … It is anticipated that initial expenditure will be in the region of £18m in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. "

Award Criteria
Training and Education Valu 9
Sales, Service & Quality 9
Performance 12
Social Value Criterion Name: Fighting Climate Change 10
Social Value Criterion Name; Covid recovery – Services, Technology, Solutions, and Innovation 10
price 50
2 Spinal Cord Stimulation

"Neuromodulation Product range to include, but not limited to the supply of; Spinal cord Stimulation. … It is anticipated that initial expenditure will be in the region of £34m in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. "

Award Criteria
Training and Education 9
Sales, Service & Quality 9
Performance 12
Social Value Criterion Name: Fighting Climate Change 10
Social Value Criterion Name; Covid recovery – Services, Technology, Solutions, and Innovation 10
price 50
3 Additional Neuromodulation Therapies and Associated Products

Neuromodulation Product range to include, but not limited to the supply of; Sacral Nerve, Vagal Nerve, Dorsal Route ganglion, Peripheral Nerve, Radio Frequency Pain Management, Intrathecal Brug Delivery Pumps and Dorsal Ramus Medial Branch nerve. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £32m in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

Award Criteria
Training and Education 15
Sales, Service & Quality 15
Social Value Criterion Name: Fighting Climate Change 10
Social Value Criterion Name; Covid recovery – Services, Technology, Solutions, and Innovation 10
price 50

Award Detail

1 Abbott Medical Ukltd (Solihull)
  • Deep Brain Stimulation
  • Reference: 034841-2023-project_1185-1
  • Value: £90,000,000 [share]
  • Awarded to group of suppliers.
2 Boston Scientific (London)
  • Deep Brain Stimulation
  • Reference: 034841-2023-project_1185-1
  • Value: £90,000,000 [share]
  • Awarded to group of suppliers.
3 Far From Surgical Solutions (Merthyr Tydfil)
  • Deep Brain Stimulation
  • Reference: 034841-2023-project_1185-1
  • Value: £90,000,000 [share]
  • Awarded to group of suppliers.
4 Medtronic (Watford)
  • Deep Brain Stimulation
  • Reference: 034841-2023-project_1185-1
  • Value: £90,000,000 [share]
  • Awarded to group of suppliers.
5 Precisis (Heidelberg)
  • Deep Brain Stimulation
  • Reference: 034841-2023-project_1185-1
  • Value: £90,000,000 [share]
  • Awarded to group of suppliers.
6 Abbott Medical Ukltd (Solihull)
  • Spinal Cord Stimulation
  • Reference: 034841-2023-2
  • Value: £156,000,000 [share]
  • Awarded to group of suppliers.
7 Boston Scientific (London)
  • Spinal Cord Stimulation
  • Reference: 034841-2023-2
  • Value: £156,000,000 [share]
  • Awarded to group of suppliers.
8 Medtronic (Watford)
  • Spinal Cord Stimulation
  • Reference: 034841-2023-2
  • Value: £156,000,000 [share]
  • Awarded to group of suppliers.
9 Saluda Medical (Harrogate)
  • Spinal Cord Stimulation
  • Reference: 034841-2023-2
  • Value: £156,000,000 [share]
  • Awarded to group of suppliers.
10 Nevro Medical (Cheltenham)
  • Spinal Cord Stimulation
  • Reference: 034841-2023-2
  • Value: £156,000,000 [share]
  • Awarded to group of suppliers.
11 Abbott Medical Ukltd (Solihull)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.
12 Avanos Medical (Redhill)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.
13 Axonics Modulation Technologies (London)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.
14 BVM Medical (Hinckley)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.
15 Charco Neurotech (Cambridge)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.
16 Electrocore (Lancing)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.
17 Far From Surgical Solutions (Loughborough)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.
18 Flow Neuroscience (Malmo)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.
19 Freedom Neuro (Breda)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.
20 Inspire Medical Systems (Minnesota)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.
21 Livanova (Gloucester)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.
22 Mainstay Medical Distribution (Santry)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.
23 Medtronic (Watford)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.
24 Nyxoah (Mont Saint Guibert)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.
25 P14 Medical (Gloucestershire)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.
26 Phagenesis (Manchester)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.
27 Polar Medical (Bethersden)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.
28 Inomed Neurocare (London)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.
29 Optimus Medical (Nottinghamshire)
  • Additional Neuromodulation Therapies and Associated Products
  • Reference: 034841-2023-3
  • Value: £146,000,000 [share]
  • Awarded to group of suppliers.

CPV Codes

  • 33158210 - Stimulator

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains